|
Volumn 45, Issue 5, 2013, Pages 2032-2033
|
Mortality After Steroid-Resistant Acute Cellular Rejection and Chronic Rejection Episodes in Adult Intestinal Transplants: Report From a Single Center in Induction/Preconditioning Era
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
DACLIZUMAB;
INFLIXIMAB;
OKT 3;
THYMOCYTE ANTIBODY;
IMMUNOSUPPRESSIVE AGENT;
STEROID;
ACUTE GRAFT REJECTION;
ALLOGRAFT;
ARTICLE;
CHRONIC GRAFT REJECTION;
CLINICAL ARTICLE;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE GRAFT;
PRIORITY JOURNAL;
SEPSIS;
STEROID RESISTANT ACUTE CELLULAR REJECTION;
SURGICAL MORTALITY;
ACUTE DISEASE;
ADULT;
CHRONIC DISEASE;
GRAFT REJECTION;
INTESTINE;
MORTALITY;
TRANSPLANTATION;
ACUTE DISEASE;
ADULT;
CHRONIC DISEASE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINES;
STEROIDS;
TRANSPLANTATION CONDITIONING;
|
EID: 84893001938
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2012.09.124 Document Type: Article |
Times cited : (10)
|
References (5)
|